ReviewCureus2022

Bevacizumab-Induced Hypertension as a Potential Physiological Clinical Biomarker for Improved Outcomes in Patients With Recurrent Glioblastoma Multiforme: A Systematic Review.

Kokab Irfan Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.